Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “De Novo”

1,171 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,171 results

Not applicableNot Yet RecruitingNCT07204600
What this trial is testing

Prevalence & Risk Factors of De Novo (MASLD) Post Liver Transplant

Who this might be right for
Post Liver Tranзplant
Assiut University 100
Not applicableStudy completedNCT00521430
What this trial is testing

Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more
Asan Medical Center 30
Not applicableStudy completedNCT03817801
What this trial is testing

Comparison of Scoring Balloon and Conventional Balloon Predilation Before Drug Coated Balloon for de Novo Lesion in Patients With High Bleeding Risk

Who this might be right for
Coronary Artery Disease
Nanjing First Hospital, Nanjing Medical University 60
Not applicableStudy completedNCT00792753
What this trial is testing

Elixir Medical Clinical Evaluation of the Novolimus-Eluting Coronary Stent System: A Randomized Study "EXCELLA II STUDY"

Who this might be right for
Coronary Artery Disease
Elixir Medical Corporation 360
Early research (Phase 1)Looking for participantsNCT05292664
What this trial is testing

Venetoclax Basket Trial for High Risk Hematologic Malignancies

Who this might be right for
Myelodysplastic Syndromes, de NovoMyelodysplastic Syndromes, SecondaryMyelodysplastic Syndromes, Previously Treated+8 more
Andrew E. Place, MD 30
Testing effectiveness (Phase 2)Looking for participantsNCT07045909
What this trial is testing

Efficacy and Safety of Anitocabtagene Autoleucel in Participants With Newly Diagnosed Multiple Myeloma (GEM-AnitoFIRST)

Who this might be right for
De Novo Multiple MyelomaAnitocabtagene Autoleucel
PETHEMA Foundation 30
Testing effectiveness (Phase 2)UnknownNCT03188198
What this trial is testing

Risk Adapted Therapy in Diffuse Large B Cell Lymphoma

Who this might be right for
Large B Cell Lymphoma
Mansoura University 60
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)WithdrawnNCT01652014
What this trial is testing

Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+51 more
University of Medicine and Dentistry of New Jersey
Post-approval studies (Phase 4)Study completedNCT00199004
What this trial is testing

Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab

Who this might be right for
Adult Acute Lymphocytic Leukemia
Johann Wolfgang Goethe University Hospital 60
Post-approval studies (Phase 4)UnknownNCT01969630
What this trial is testing

Paclitaxel-eluting Balloon Angioplasty With Provisional Use of Nitinol Stent Versus Systematic Implantation of Paclitaxel-eluting Stent for the Treatment of Femoropopliteal de Novo Lesions

Who this might be right for
Peripheral Artery Disease
Ospedale San Donato 250
Not applicableActive Not RecruitingNCT02698852
What this trial is testing

Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES)

Who this might be right for
Coronary Artery Disease
Sino Medical Sciences Technology Inc. 1,000
Post-approval studies (Phase 4)Study completedNCT02765399
What this trial is testing

The Effect of Liraglutide Treatment on Postprandial Chylomicron and VLDL Kinetics, Liver Fat and de Novo Lipogenesis

Who this might be right for
Type 2 Diabetes
Helsinki University Central Hospital 23
Testing effectiveness (Phase 2)Study completedNCT01839916
What this trial is testing

Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+61 more
University of Chicago 77
Post-approval studies (Phase 4)Study completedNCT00817687
What this trial is testing

The Impact of an Early Biopsy in Patients Treated With CellCept (Mycophenolate Mofetil) After Kidney Transplantation

Who this might be right for
Kidney Transplantation
Hoffmann-La Roche 66
Large-scale testing (Phase 3)UnknownNCT05179733
What this trial is testing

The Efficacy and Safety of ZR2 Versus R-miniCHOP in the Treatment of Unfit or Frail de Novo Diffuse Large B-cell Lymphoma Patients Aged Older Than or Equal to 70 Years

Who this might be right for
Diffuse Large B-Cell Lymphoma
Ruijin Hospital 280
Large-scale testing (Phase 3)Study completedNCT00782145
What this trial is testing

A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+6 more
Tufts Medical Center 198
Not applicableStudy completedNCT01906463
What this trial is testing

Social and Prognostic Inequalities in Patients Hospitalised for Cerebrovascular Accident (CVA) in Four Contrasting French Departments

Who this might be right for
Symptomatic CVA (de Novo CVA)
Centre Hospitalier Universitaire Dijon 1,612
Not applicableStudy completedNCT00314275
What this trial is testing

The ENDEAVOR Pharmacokinetic (PK) Registry: The Medtronic Endeavor Drug Eluting Coronary Stent System

Who this might be right for
Coronary Artery Disease
Medtronic Vascular 43
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05931757
What this trial is testing

Olverembatinib Combined With Blinatumomab in the Treatment of Ph+ ALL

Who this might be right for
Philadelphia-Positive ALL
The First Affiliated Hospital of Soochow University 22
Load More Results